End Of Year Summary



    Clifton Mining Company Inc. (OTC : CFTN)

    ALPINE, UT, Jan. 16 /CNW/ -

    End Of Year Summary
    -------------------
    In 2007, Clifton's joint venture partner discovered another gold-bearing
zone. Known mineralization now include the Kiewit gold mineralization, the
Cane Springs gold mineralization, and now the Rattler Ridge gold
mineralization.
    Clifton has a significant investment in American Biotech Labs(R), LLC
(ABL). ABL is a private biotech company that produces a silversol, a potent
yet benign anti-pathogenic. ABL's annual sales increased by 25%, to $4 million
in 2007 with ongoing research and patent filings. Clifton received a cash
dispersment from ABL for the 2007 sales year.

    The Gold Properties
    -------------------
    The Kiewit property has been intensively drilled and estimates range
between 75,000-250,000 ounces of recoverable gold. The venture is progressing
toward a full feasibility study. Increasing gold prices add significantly
because to minable reserves, as higher values increase cut off grades.
    Phase one drilling has been completed at the Cane Springs mine. An
additional gold bearing structure was found and drilled adjacent to the
historic mine. Like the historic mine, high-grade gold values were found, with
some drill sections showing multi-ounce values of gold. Initial estimates
indicate that this area may contain 100,000-200,000 ounces of gold. Clifton
has filed for a mine permit for the Cane Springs mine, and expects to have the
permit in hand within the next few months. Phase one drilling on the Rattler
Ridge project has been completed. A number of the completed drill holes
penetrated gold mineralization. Phase two drilling is now being planned for
the spring.

    Other Mining News
    -----------------
    The management of Clifton has filed with the Department Of Oil, Gas, and
Mining for another mine permit to cover the Clifton silver veins area of the
property. Management expects that permit to be granted within the next few
months.

    American Biotech Labs
    ---------------------
    New products including the new gel products that came on line in August
helped achieve a significant increase in sales. Management expects that new
accounts in Europe, Asia, Middle East, and Africa will start to purchase
product by mid-2008. ABL completed its new production facility, including
bottling, gel manufacturing, and tubing facilities in 2007. The new facility,
increased monthly production capacity to 1.5 million bottles. The new plant
has received government approval to produce product and the plant is currently
in operation. The company expects a number of articles on the Silversol
Technology(TM) to be published in 2008, including one in conjunction with
testing completed by the U.S. Military and another related to the H5-N1 Bird
Flu.

    Clifton trades on the U.S. OTC: (CFTN).

    Note: Any statements released by Clifton Mining Company that are forward
looking are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Editors and investors are cautioned
that forward looking statements invoke risk and uncertainties that may affect
the company's business prospects and performance.





For further information:

For further information: Dr. Ken Friedman, President at (303) 642-0659;
Keith Moeller, Vice President at (801) 756-1414 or see the websites at
www.cliftonmining.com and www.americanbiotechlabs.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890